Spero Therapeutics (2HA.STU) Q2 2026 Earnings

13MayConfirmed
Q1 2026
Next
-0.17
0.04
0.25
0.46

Details

Expected EPS
-0.1528182
Actual EPS
N/A
Surprise EPS
0.15
Surprise Percent
+100%

Description

Spero Therapeutics (2HA.STU) will report earnings of for Q2 2026 on May 13, 2026.

0 Comments

Share your thoughts